Koru Medical Systems Inc. (KRMD) Insider Trading
Insiders bought $1.63M on the open market and sold nothing.
Get an email when KRMD's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 8 | Adam R Kalbermatten Chief Commercial Officer | Bought | 32,000 | $3.16 | $101k | 8.8% | Form 4 |
| Jun 11 | Adam R Kalbermatten President-Chief Commercial Off | Bought 2 parts | 12,500 | $3.94 average | $49k | 2.1% | Form 4 |
| May 18 | Eric Schiller Chief Technology Officer | Bought | 5,000 | $3.91 | $20k | New | Form 4 |
| May 15 | Linda M Tharby Chief Executive Officer | Bought | 1,191 | $1,191.00 | $1.42M | 0.2% | Form 4 |
| May 15 | Linda M Tharby Chief Executive Officer | Bought | 1,191 | $3.92 | $5k | 0.2% | Form 4 |
| May 14 | Christopher Pazdan Chief Operating Officer | Bought | 5,000 | $3.88 | $19k | 1.7% | Form 4 |
| May 14 | Thomas Edward Adams Chief Financial Officer | Bought 2 parts | 5,500 | $3.86 average | $21k | 1.8% | Form 4 |
- Sep 8Adam R KalbermattenChief Commercial Officer · bought 32,000 at $3.16$101k8.8% of stake
- Jun 11Adam R KalbermattenPresident-Chief Commercial Off · bought 12,500 at avg $3.94$49k2.1% of stake
- May 18Eric SchillerChief Technology Officer · bought 5,000 at $3.91$20kNew position
- May 15Linda M TharbyChief Executive Officer · bought 1,191 at $1,191.00$1.42M0.2% of stake
- May 15Linda M TharbyChief Executive Officer · bought 1,191 at $3.92$5k0.2% of stake
- May 14Christopher PazdanChief Operating Officer · bought 5,000 at $3.88$19k1.7% of stake
- May 14Thomas Edward AdamsChief Financial Officer · bought 5,500 at avg $3.86$21k1.8% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Surgical & Medical Instruments & Apparatus
Spot a number that looks wrong? Check it in KRMD's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing KRMD
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.